Valuation: Certara, Inc.

Market Cap 1.84B 1.65B 1.51B 1.38B 2.6B 173B 2.68B 18.18B 7.24B 92.17B 6.9B 6.75B 291B P/E 2026 *
-42.7x
P/E 2027 * 153x
Enterprise Value 1.9B 1.7B 1.55B 1.42B 2.68B 178B 2.77B 18.77B 7.48B 95.16B 7.12B 6.97B 301B EV / Sales 2026 *
5.01x
EV / Sales 2027 * 4.68x
Free-Float
67.07%
Yield 2026 *
-
Yield 2027 * -
1 day-1.07%
1 week+9.35%
Current month+9.35%
1 month+34.49%
3 months+46.95%
6 months+90.97%
Current year+36.78%
1 week 10.46
Extreme 10.4598
12.61
1 month 8.64
Extreme 8.64
12.61
Current year 4.45
Extreme 4.45
12.61
1 year 4.45
Extreme 4.45
12.61
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
43.75
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 31/12/2025
Director of Finance/CFO 53 14/07/2026
Chief Tech/Sci/R&D Officer - 30/07/2025
Director TitleAgeSince
Chairman 72 30/11/2021
Director/Board Member 68 31/12/2012
Director/Board Member 59 31/07/2017
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Chief Financial Officer

63,532 0.0416%
15/07/26 Other

Chief Financial Officer

191,850 0.1233%
01/06/26 Exercice

General Counsel

57,763 0.0371%
Change 5-day change 1-year change 3-year change Capi.($)
-1.07%+9.35%+38.99%-4.21% 1.84B
-0.99%+1.67%+6.80%+47.17% 3,940B
+3.48%-12.89%-9.86%+753.09% 386B
+0.82%-11.15%-51.48%+6.52% 362B
-2.32%-0.24%-2.27%+59.95% 271B
-0.26%-14.22%+47.84%+159.29% 256B
-0.14%-13.39%+60.72%+351.03% 223B
+9.86%+71.21%-36.89%+856.76% 130B
-0.38%-3.00%-40.84%-16.95% 106B
-2.90%-4.37%-26.81%-59.11% 93.14B
Average +0.61%+1.66%-1.38%+215.35% 576.93B
Weighted average by Cap. -0.35%-0.50%+3.12%+124.49%

Financials

2026 *2027 *
Net sales 379M 340M 310M 284M 535M 35.59B 552M 3.75B 1.49B 19.01B 1.42B 1.39B 60.04B 389M 349M 318M 291M 549M 36.51B 567M 3.85B 1.53B 19.5B 1.46B 1.43B 61.59B
Net income -30.84M -27.68M -25.26M -23.1M -43.55M -2.9B -44.93M -305M -122M -1.55B -116M -113M -4.88B 4.02M 3.61M 3.29M 3.01M 5.68M 378M 5.86M 39.78M 15.85M 202M 15.1M 14.77M 637M
Net Debt 59.79M 53.67M 48.96M 44.79M 84.43M 5.61B 87.11M 591M 236M 3B 224M 220M 9.47B -19.92M -17.88M -16.32M -14.92M -28.13M -1.87B -29.03M -197M -78.52M -999M -74.77M -73.17M -3.16B
Projected Income Statement - Annual - Certara, Inc.
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.
Employees
1,546
Date Price Change Volume
06/11/26 US$12.05 -1.07% 4,871,056
05/11/26 US$12.18 +9.83% 3,733,152
04/11/26 US$11.09 +2.02% 2,425,078
03/11/26 US$10.87 +1.49% 1,869,817
02/11/26 US$10.71 -2.81% 1,951,991
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
MarketScreener Ratings - Certara, Inc.
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
12.05USD
Average target price
11.81USD
Spread / Average Target
-2.00%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Certara, Inc.
  1. Stock Market
  2. Stocks
  3. CERT Stock